DERM Journey Medical Corp
Fundamentals / CIK 0001867066 / USDJourney Medical Corp reported $69.52M in revenue and a net loss of $5.10M for the trailing twelve months ended September 30, 2026 (up 7.6% year over year), with a 65.9% gross margin and a -2.9% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DERM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$69.52M +7.6% YoY
-
Operating Income TTM-$2.01M -2.9% margin
-
Net Income TTM-$5.10M -7.3% net margin
-
Diluted EPS TTM-$0.18 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$22.32M Total debt: $25.62M
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $61.86M | $56.13M | $79.18M | $73.67M | $63.13M | $44.53M |
| Cost of Revenue | $20.92M | $20.88M | $22.89M | $30.77M | $32.08M | $14.59M |
| Gross Profit | $40.93M | $35.26M | $56.29M | $42.89M | $31.05M | $29.94M |
| Research & Development | $480K | $9.86M | $7.54M | $10.94M | $2.74M | -- |
| Selling, General & Admin | $44.37M | $40.20M | $43.91M | $59.47M | $39.83M | $22.09M |
| Operating Income | -$8.17M | -$13.68M | -$2.07M | -$27.52M | -$34.88M | $7.85M |
| EBITDA | -- | -- | -- | -- | -$34.88M | $7.86M |
| Interest Expense | $3.70M | $2.70M | $1.70M | $2.02M | $7.03M | $698K |
| Income Before Tax | -$11.37M | -$14.61M | -$3.63M | -$29.57M | -$42.36M | $7.15M |
| Income Tax Expense | $60K | $61K | $221K | $63K | $1.63M | $1.87M |
| Net Income | -$11.43M | -$14.67M | -$3.85M | -$29.63M | -$43.99M | $5.28M |
| Basic EPS | -$0.47 | -$0.72 | -$0.21 | -$1.69 | -$4.32 | $0.58 |
| Diluted EPS | -$0.47 | -$0.72 | -$0.21 | -$1.69 | -$4.32 | $0.49 |
| Basic Shares Outstanding | 24.5M | 20.4M | 18.2M | 17.5M | 10.2M | 9.1M |
| Diluted Shares Outstanding | 24.5M | 20.4M | 18.2M | 17.5M | 10.2M | 10.8M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.97M | $18.51M | $15.96M | $16.08M | $17.63M | $15.01M | $13.14M | $13.62M |
| Cost of Revenue | $5.88M | $6.14M | $6.22M | $5.44M | $5.75M | $4.94M | $4.79M | $2.24M |
| Gross Profit | $13.08M | $12.37M | $9.74M | $10.64M | $11.88M | $10.07M | $8.35M | $11.38M |
| Research & Development | $51K | $54K | -- | $154K | $287K | $0 | $39K | $218K |
| Selling, General & Admin | $12.59M | $10.89M | $10.11M | $9.86M | $12.05M | $11.88M | $10.57M | $10.06M |
| Operating Income | -$530K | $456K | -$1.49M | -$443K | -$1.53M | -$2.88M | -$3.32M | $2.23M |
| Interest Expense | $919K | $906K | $892K | $933K | $937K | $937K | $891K | $831K |
| Income Before Tax | -$1.31M | -$297K | -$2.23M | -$1.25M | -$2.31M | -$3.74M | -$4.07M | $1.58M |
| Income Tax Expense | $0 | $15K | -- | -- | -- | $60K | -- | -- |
| Net Income | -$1.31M | -$312K | -$2.23M | -$1.25M | -$2.31M | -$3.80M | -$4.07M | $1.52M |
| Basic EPS | -$0.05 | -$0.01 | -$0.08 | -- | -$0.09 | -$0.16 | -$0.18 | -- |
| Diluted EPS | -$0.05 | -$0.01 | -$0.08 | -- | -$0.09 | -$0.16 | -$0.18 | -- |
| Basic Shares Outstanding | 28.1M | 27.5M | 27.3M | -- | 25.0M | 23.3M | 22.6M | -- |
| Diluted Shares Outstanding | 28.1M | 27.5M | 27.3M | -- | 25.0M | 23.3M | 22.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $24.09M | $20.30M | $27.44M | $32.00M | $49.08M | $8.25M |
| Cash & Short-Term Investments | $24.09M | $20.30M | $27.44M | $32.00M | $49.08M | $8.25M |
| Accounts Receivable, Net | $29.78M | $10.23M | $15.22M | $28.21M | $23.11M | $23.93M |
| Inventory | $9.62M | $14.43M | $10.21M | $14.16M | $9.86M | $1.40M |
| Total Current Assets | $66.87M | $48.18M | $56.45M | $77.68M | $84.49M | $35.24M |
| Intangible Assets | $27.61M | $31.86M | $20.29M | $27.20M | $12.55M | $15.03M |
| Other Non-Current Assets | -- | -- | $6.0K | $95K | $150K | $6.0K |
| Total Non-Current Assets | $27.72M | $32.06M | $20.39M | $27.48M | $12.79M | $16.66M |
| Total Assets | $94.59M | $80.24M | $76.85M | $105.2M | $97.28M | $51.91M |
| Accounts Payable | $8.85M | $16.05M | $18.15M | $36.57M | $22.81M | $1.84M |
| Other Current Liabilities | $455K | $528K | $195K | $413K | -- | -- |
| Total Current Liabilities | $37.44M | $35.17M | $41.87M | $66.83M | $51.61M | $28.06M |
| Long-Term Debt | $25.28M | $24.88M | $14.62M | $19.83M | -- | -- |
| Total Non-Current Liabilities | $25.30M | $25.00M | $14.63M | $21.35M | $3.63M | $13.55M |
| Total Liabilities | $62.74M | $60.17M | $56.50M | $88.18M | $55.24M | $41.61M |
| Total Debt (incl. Leases) | $25.40M | $25.08M | $14.73M | $20.02M | $98K | $182K |
| Retained Earnings | -$98.46M | -$87.03M | -$72.36M | -$68.50M | -$38.87M | $5.12M |
| Total Stockholders' Equity | $31.85M | $20.07M | $20.35M | $16.98M | $42.04M | $10.29M |
| Total Equity | $31.85M | $20.07M | $20.35M | $16.98M | $42.04M | $10.29M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $22.32M | $25.64M | $27.22M | $24.09M | $24.95M | $20.29M | $21.07M | $20.30M |
| Cash & Short-Term Investments | $22.32M | $25.64M | $27.22M | $24.09M | $24.95M | $20.29M | $21.07M | $20.30M |
| Accounts Receivable, Net | $47.39M | $36.25M | $24.99M | $29.78M | $17.98M | $15.64M | $18.02M | $10.23M |
| Inventory | $7.77M | $8.16M | $9.29M | $9.62M | $11.82M | $12.85M | $12.50M | $14.43M |
| Total Current Assets | $79.26M | $72.78M | $64.97M | $66.87M | $56.39M | $51.27M | $53.99M | $48.18M |
| Intangible Assets | $24.54M | $25.51M | $26.48M | $27.61M | $28.67M | $29.73M | $30.80M | $31.86M |
| Total Non-Current Assets | $24.58M | $25.57M | $26.57M | $27.72M | $28.80M | $29.89M | $30.98M | $32.06M |
| Total Assets | $103.8M | $98.36M | $91.53M | $94.59M | $85.19M | $81.16M | $84.96M | $80.24M |
| Accounts Payable | $9.40M | $8.05M | $8.20M | $8.85M | $11.56M | $12.75M | $14.40M | $16.05M |
| Short-Term Debt | $7.50M | $5.00M | $2.50M | -- | $5.62M | $3.75M | $1.88M | -- |
| Other Current Liabilities | $812K | $405K | $472K | $455K | $755K | $840K | $399K | $528K |
| Total Current Liabilities | $53.52M | $45.77M | $37.83M | $37.44M | $39.72M | $40.48M | $40.22M | $35.17M |
| Long-Term Debt | $18.08M | $20.47M | $22.87M | $25.28M | $19.53M | $21.36M | $23.11M | $24.88M |
| Total Non-Current Liabilities | $18.08M | $20.47M | $22.87M | $25.30M | $19.58M | $21.43M | $23.20M | $25.00M |
| Total Liabilities | $71.60M | $66.24M | $60.70M | $62.74M | $59.29M | $61.91M | $63.42M | $60.17M |
| Total Debt (incl. Leases) | $25.62M | $25.54M | $25.47M | $25.40M | $25.30M | $25.28M | $25.17M | $25.08M |
| Retained Earnings | -$102.3M | -$101.0M | -$100.7M | -$98.46M | -$97.21M | -$94.90M | -$91.10M | -$87.03M |
| Total Stockholders' Equity | $32.25M | $32.11M | $30.83M | $31.85M | $25.90M | $19.25M | $21.54M | $20.07M |
| Total Equity | $32.25M | $32.11M | $30.83M | $31.85M | $25.90M | $19.25M | $21.54M | $20.07M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$11.43M | -$14.67M | -$3.85M | -$29.63M | -$43.99M | $5.28M |
| Depreciation & Amortization | -- | -- | -- | -- | $0 | $5.0K |
| Stock-Based Compensation | $6.29M | $6.10M | $2.61M | $4.42M | $2.47M | $153K |
| Change in Receivables | -$19.34M | $4.47M | $12.55M | -$5.38M | $768K | -$5.02M |
| Change in Inventory | $4.81M | -$4.22M | $3.95M | $1.74M | -$8.46M | -$547K |
| Change in Payables | -$7.20M | -$2.10M | -$18.42M | $14.34M | $20.39M | -$204K |
| Operating Cash Flow | -$12.44M | -$9.13M | $5.24M | -$13.53M | -$2.18M | $5.13M |
| Capital Expenditure | -- | -$15.00M | -$5.00M | -$20.00M | -- | -- |
| Free Cash Flow | -- | -$24.13M | $240K | -$33.53M | -- | -- |
| Investing Cash Flow | -- | -$15.00M | -$5.00M | -$20.00M | -$10.00M | -$1.20M |
| Common Stock Issued | $16.36M | $7.88M | $4.49M | -- | $32.54M | -- |
| Financing Cash Flow | $16.23M | $16.99M | -$4.80M | $16.46M | $53.02M | -$487K |
| Net Change in Cash | $3.79M | -$7.13M | -$4.56M | -$17.08M | $40.84M | $3.44M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.31M | -$312K | -$2.23M | -$1.25M | -$2.31M | -$3.80M | -$4.07M | $1.52M |
| Stock-Based Compensation | $1.33M | $1.44M | $989K | $1.77M | $1.85M | $1.34M | $1.32M | $1.38M |
| Change in Receivables | -$11.20M | -$11.24M | $4.76M | -$11.76M | -$2.42M | $2.82M | -$7.99M | $747K |
| Change in Inventory | $384K | $1.14M | $332K | $2.19M | $1.03M | -$356K | $1.94M | -$2.64M |
| Change in Payables | $1.35M | -$153K | -$649K | -$2.71M | -$1.20M | -$1.65M | -$1.65M | $711K |
| Operating Cash Flow | -$3.44M | -$1.73M | $2.91M | -$6.28M | -$2.38M | -$942K | -$2.83M | $2.23M |
| Common Stock Issued | -- | -- | -- | $5.42M | $6.89M | $0 | $4.05M | $6.20M |
| Financing Cash Flow | $117K | $158K | $220K | $5.43M | $7.04M | $165K | $3.60M | $10.62M |
| Net Change in Cash | -$3.32M | -$1.58M | $3.13M | -$858K | $4.66M | -$777K | $765K | -$2.16M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Gross Margin | 66.2% | 62.8% | 71.1% | 58.2% | 49.2% | 67.2% |
| Operating Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | 17.6% |
| Net Profit Margin | -18.5% | -26.1% | -4.9% | -40.2% | -69.7% | 11.9% |
| Return on Equity (ROE) | -35.9% | -73.1% | -18.9% | -174.5% | -104.6% | 51.3% |
| Return on Assets (ROA) | -12.1% | -18.3% | -5.0% | -28.2% | -45.2% | 10.2% |
| Current Ratio | 1.79x | 1.37x | 1.35x | 1.16x | 1.64x | 1.26x |
| Quick Ratio | 1.53x | 0.96x | 1.10x | 0.95x | 1.45x | 1.21x |
| Debt to Equity | 0.80x | 1.25x | 0.72x | 1.18x | 0.00x | 0.02x |
| Revenue Growth (YoY) | +10.2% | -29.1% | +7.5% | +16.7% | +41.8% | -- |
| Gross Profit Growth (YoY) | +16.1% | -37.4% | +31.2% | +38.1% | +3.7% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -544.3% | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -932.7% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -844.8% | -- |
| Operating Cash Flow Growth (YoY) | -- | -274.2% | -- | -- | -142.5% | -- |
| Free Cash Flow Growth (YoY) | -- | -10152.9% | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -48.2% | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -180.7% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.9% | 65.5% | 65.4% | 66.2% | 70.2% | 69.4% | 66.5% | 62.8% |
| Operating Margin | -2.9% | -4.4% | -9.8% | -13.2% | -9.3% | -12.2% | -12.3% | -24.4% |
| Net Profit Margin | -7.3% | -9.0% | -14.8% | -18.5% | -14.6% | -15.5% | -14.8% | -26.1% |
| Return on Equity (ROE) | -15.8% | -19.0% | -31.1% | -35.9% | -33.5% | -45.4% | -38.5% | -73.1% |
| Return on Assets (ROA) | -4.9% | -6.2% | -10.5% | -12.1% | -10.2% | -10.8% | -9.8% | -18.3% |
| Current Ratio | 1.48x | 1.59x | 1.72x | 1.79x | 1.42x | 1.27x | 1.34x | 1.37x |
| Quick Ratio | 1.34x | 1.41x | 1.47x | 1.53x | 1.12x | 0.95x | 1.03x | 0.96x |
| Debt to Equity | 0.79x | 0.80x | 0.83x | 0.80x | 0.98x | 1.31x | 1.17x | 1.25x |
| Revenue Growth (YoY) | +7.6% | +23.3% | +21.5% | +18.1% | +20.5% | +1.0% | +0.8% | -10.7% |
| Gross Profit Growth (YoY) | +10.2% | +22.8% | +16.7% | -6.5% | +27.1% | +21.1% | +34.4% | -12.5% |
| Operating Income Growth (YoY) | -- | -- | -- | -119.8% | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -182.0% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -382.4% | -- | -- | -- | -- |